Return...
Leadership
Jamey Weichert, Ph.D., Chairman & CSO, Associate Professor, Depts. of Radiology, Medical Physics, Pharmaceutics and member of the Comprehensive Cancer Center, University of Wisconsin, Madison. Dr. Weichert is the primary founder of Cellectar. He has a bachelors degree in chemistry from the University of Minnesota and a doctorate in medicinal chemistry from the University of Michigan (1985). His research interests include the design, synthesis and evaluation of biomimetic CT and MRI imaging agents and radiopharmaceuticals. He has been involved in molecularly targeted imaging agent development his entire professional career and has developed or co-developed several imaging agents nearing clinical trial status. Dr. Weichert serves or has served on the editorial boards of numerous scientific journals and has authored more than 40 peer reviewed publications and 100 abstracts. He also has 20 issued or pending patents related to drug delivery, imaging and contrast agent development.
Ernest Allen, Director of Clinical Operations, Mr. Allen brings more than 20 years of experience in the pharmaceutical industry. He has held progressively senior positions in clinical operations for a number of companies including: Alcon, Amgen, Parke-Davis, and Origin Pharmaceuticals, Inc.,a U.K. based contract research organization (CRO) where he served as Senior Clinical Manager. Mr. Allen has worked for six years as an independent consultant supporting pharmaceutical and biotechnology companies in the development of their clinical programs. Most recently, he was Clinical Manager for Tapestry Pharmaceuticals, Inc., a cancer treatment pharmaceutical company.
|
